Clinical trial
Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis…
NCT00047060 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00047060 |
|---|---|
| Title | Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome |
| Official title | A Phase I/II Study of HLA-matched Mobilized Peripheral Blood Hematopoietic Stem Cell Transplantation for Advanced Mycosis Fungoides/Sezary Syndrome Using Nonmyeloablative Conditioning With Campath-1H |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Mycosis Fungoides, Sezary Syndrome |
| Intervention type | Drug, Other |
| Interventions | A matched peripheral donor stem cells, cyclosporine, fludarabine, Campath |
| Enrollment | 5 |
| Start date | Jul 30, 2002 |
| Primary completion | Jan 24, 2019 |
| Completion | Jan 24, 2019 |
| First posted | Jan 27, 2003 |
| Last update posted | Nov 14, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: